--- title: "EXPRESSION THERAPEUTICS, INC. — Capability Statement" uei: "PBQBKK5QY571" cage: "480J9" canonical: "https://teamingindex.com/contractor/PBQBKK5QY571/capability.md" html_url: "https://teamingindex.com/contractor/PBQBKK5QY571" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "EXPRESSION THERAPEUTICS, INC." dba_name: "EXPRESSION THERAPEUTICS LLC" primary_naics: "541714" sam_status: "active" active_exclusion: false claimed: false tier: "unclaimed" --- # EXPRESSION THERAPEUTICS, INC. > EXPRESSION THERAPEUTICS, INC. (DBA EXPRESSION THERAPEUTICS LLC) is a SAM.gov-registered entity based in TUCKER, GA 30084-5709. UEI PBQBKK5QY571; CAGE 480J9; primary NAICS 541714. Compliance posture not provided. Active SAM registration. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** EXPRESSION THERAPEUTICS, INC. - **DBA name:** EXPRESSION THERAPEUTICS LLC - **UEI (SAM.gov Unique Entity ID):** PBQBKK5QY571 - **CAGE code:** 480J9 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** GA - **Website:** - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** TUCKER, GA 30084-5709 - **Country:** United States - **Congressional district:** GA-05 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | Yes | Yes | - **PSC codes:** None on file Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status - Small Business (SB) Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** Active SAM registration - **Registration expires:** 2027-04-20 - **Registration activated:** 2026-04-22 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $0 - **Award history:** 0 awards on record No federal prime awards on record (USAspending.gov). ## Proven teaming graph - No first-tier sub-award reports name this company yet - Source: USAspending.gov sub-award reports (FSRS), sync date not recorded. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 16 SBIR/STTR awards totaling $9.9M: SBIR Phase I 9, SBIR Phase II 3, STTR Phase I 2, STTR Phase II 2 - By agency: Department of Health and Human Services 16 - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2025, Dec 4, 2024 to Nov 30, 2025: Allogeneic cell and gene therapy for neuroendocrine tumors ($400,000) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2023, Sep 19, 2023 to Aug 31, 2024: ADEPT-STAR therapy for high risk neuroblastoma ($400,000) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, May 1, 2019 to Oct 31, 2020: A Microscale Platform for Augmentation of Cell Transduction (MPACT) to Enhance Ex Vivo Gene Transfer ($224,999) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2018, Aug 15, 2018 to Jul 31, 2020: Clinical Testing of the First Suspension BHK-M Cell Platform Derived Biotherapeutic ($1,499,692) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2017, Feb 1, 2017 to Jul 31, 2018: Preclinical Evaluation of Ancestral Coagulation Factor VIII ($224,976) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2016, Aug 15, 2016 to Feb 28, 2018: Selection and preclinical validation of a lead candidate liver-directed AAV-FVIII expression cassette ($224,223) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2014, Apr 23, 2014 to Mar 31, 2017: Bioengineered factor VIII gene therapy for hemophilia A ($1,485,861) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2014, Feb 1, 2014 to Jan 31, 2017: Bioengineered Recombinant FVIII ($1,483,531) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2013: Manufacturing Process Development for Bioengineered FVIII ($386,432) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2012: Development of a novel production platform for complex recombinant biotherapeutic ($296,320) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - Not yet checked against SAM.gov exclusions (search exclusions on SAM.gov: https://sam.gov/search/?index=ex) - Source: SAM.gov Exclusions, sync date not recorded - No confirmed match on the Consolidated Screening List (screened Nov 13, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.